Cancer BiologybioRxivPreprint
Optimized dosing of spatially heterogeneous radiopharmaceutical therapy reprograms poorly immunogenic tumors to enhance response to immune checkpoint blockade
Maya E. Takashima, Zachary Danaceau, Malick Bio Idrissou…·Zachary Scott Morris
This study shows that optimized spatially heterogeneous radiopharmaceutical therapy enhances immune checkpoint blockade response in poorly immunogenic tumors by promoting T cell activation and infiltration.
DOI 10.64898/2026.10.27.762270